Rimonabant Acomplia

The Zimulti Acomplia Report

Now that a promising new prescription weight loss drug, rimonabant, it is today available in the U.K., Germany and 44 other countries, the launch of the most anticipated weight-loss Drug since Fen-phen is generating a great deal of excitement among millions of obese people  and seriously overweight Americans and Europeans.
The medication, sold in Europe as Acomplia, may ultimately be sold in the United States as Zimulti — but that day seems to be  several years off after an FDA advisory panel voted against sale of rimonabant in summer 2007 out of concern over its depressive side effects.
The Rimonabant Zimulti Acomplia Report, updated every day, will track the continuing efforts of Sanofi Avensis to get Rimonabant approved for sale on the U.S. market The Zimulti Acomplia Report also will provide news,informations and reviews about  rimonabant so those eager to try this new anti-obesity drug will have the latest information on availability, weight-loss results and side-effects.
Side effects of Acomplia Rimonabant were described as minor and temporary, the most frequent    being diarrhea, nausea, vomiting and dizziness. More severe anticipated side effects, especially    depression, did not materialize. it caused  nausea in 13% of patients, vs. in 4% of those who got    placebo.

An announcement was made about Sanofi-Aventis.This refears to  the launch of Acomplia (rimonabant), a  new  medication that treats  abdominally obese persons which presents cardio metabolic risk cluster.

This medication was approved from the European Medicines Evaluation Agency (EMEA) in order  to be used,but combined  with diet and sport and it’s ment to the treat  obesity with cardio metabolic risk cluster.People can buy Acomplia  already in more that 15 European states, including very important states like Germany and the UK.

This  new obesity drug can reduce very much the  blood sugar levels in persons which have type 2 diabetes and in the same time it helps  this persons to reduce their body weight. Acomplia way of working is  by select and block the  receptors that are located in the brain and in peripheral organs important in glucose and lipid metabolism,and that  includes the liver, gastrointestinal tract, adipose tissue, and muscle. The medication is decreasing the over activity of the endocannabinoid system (EC system). The EC system was a short time ago characterized as a physiological system that includes receptors such as the CB¹ receptor, and scienties think that in order  to play an very important role in controlling energy balance ,in regulating body weight and glucose and lipid metabolism.So it’s ok for people to use and buy acomplia.

Diet drug Acomplia (rimonabant) on Feb. 6th received a “‘favorable recommendation” for reimbursement by French health insurance companies and state social security plans for use limited to obese patients with type 2 diabetes insufficiently controlled by customary diabetes drugs.

The independent Transparency Committee, however, apparently did not recommend reimbursement for patients who are overweight or obese but not diabetics, according to a terse announcement by Sanofi-Aventis.

“The patients who may benefit from a reimbursed prescription are those associating obesity (BMI greater than or equal to 30) with type 2 diabetes, insufficiently controlled by a mono-therapy of metformin or sulfonylurea, with a HbA1c level between 6.5 and 10,” the Committee said.

The next step is for the French government to decide if it will follow this recommendation and then the proportion of the cost to be refunded.

Obesity is becoming a problem going out of hand. It is time to curtail the problem by resorting to some means or the other. Obesity is considered a disease by the medical community. It has serious health risks like heart problems, diabetes, stroke, paralysis, prostrate cancer plus a dozen of other kind of diseases.

Traditional obesity reduction methods like doing exercises and having a controlled diet are fast becoming a thing of the past. But the best available method to lose weight is a combination of exercises, diet program and diet pills.

But choosing a right diet pill is a difficult task considering the different types of diet pills available in the market today like Phentermine, Reductil, Acomplia and Alli etc., out of these drugs Alli is the only FDA-approved weight-loss product available over the counter.

The information about Acomplia diet pills can help in reducing weight. For an obese patient it is necessary to know about diet pills and how it work for weight loss.

In case of diet pills every patients should have information about weight loss pills before taking it. Having necessary information about appetite suppressant Acomplia rimonabant diet pills can help you in reducing weight.

Acomplia Rimonabant diet pills work like an appetite suppressant. The Rimonabant Acomplia blocks chemical processes directly in the brain, which cause reduce appetite, help liver to burn more fat and it might be effective drug to cure smoking and even alcohol abuse. This drug might bring a new ways of healing obesity and additional health problems.

The main task of acomplia is blocking CB-1 receptors which can be found on the surface of the cells throughout the body including fat cells. An obese patient after taking acomplia diet pill feels fullness and hence eats less food as compared to their normal diet. This process can help an obese patient to regain a perfect shape of the body.

Acomplia has been approved for sale in the UK and in some other European countries. It still awaits approval by FDA in the US. Sanofi-Aventis is planning to launch rimonabant by the name of Zimulti rather than Acomplia.

Acomplia is high efficacy diet suppressant which generally suits to the adults above the age of 18 years. Weight loss experts always suggest exercise and increasing of physical activities simultaneously with acomplia for a serious overweight patient.

Acomplia

	Review Summary
Obesity is on the rise in many countries in the world, which has created a need for pharmaceutical grade medications, which can help, those who are chronically obese and require medical intervention lose weight safely. This is where Acomplia comes into play, because it is a pharmaceutical grade anorectic anti-obesity medication sold by Sanofi-Aventis in the UK and Sanofi-Synthelabo in Denmark. As of yet it is not currently available on the US, because it has not received clearance from the proper government agencies.
	Ingredients at a Glance
Acomplia’s main ingredient is Rimonabant, which is a CB1 cannabinoid receptor antagonist, which is a complicated way of saying that it can provide users with a reduction in appetite. This is the first “CB1 cannabinoid receptor antagonist” to be approved anywhere in the world to treat obesity. However, its use is contingent upon the inclusion of a healthy diet and exercise into the lifestyle of users.
	Ingredients In Focus
Many view Rimonabant and by extension Acomplia to be the new “wonder drug” of weight loss. It has gone through a variety of clinical studies in which patients took this drug for a year, and the results were very good in terms of weight loss, improved insulin sensitivity, and increases in HDL cholesterol. These studies provided the information that precipitated its approval in Europe. However, many are watching carefully because it is the first of its kind and works very differently than any other obesity drug. It directly affects a part of the brain called the endocannabiniod system, which regulates relaxation, pain tolerance and pleasure. No one knows how directly interfering with the operation of this system will affect users in the long term. The endocannabiniod system protects the brain during any type of brain trauma; some experts have suggested that use of this product may well block the system from doing its job when it is needed during times of trauma.
	Diet Lifestyle
It is important when taking any prescribed medication to carefully review the materials enclosed in order to be aware of any possible side effects. For instance, the following side effects are associated with use of Acomplia - depression, anxiety and nausea. Also, we discovered that roughly 1 in 8 patients who were taking this medication left the study because of these side effects. It has come to our attention that Acomplia is available in the US via the internet through various overseas distributors, and we can in no way support getting this medication through this method. This is clearly a medical grade pharmaceutical which must be used under medical supervision, especially since it directly affects brain chemistry.
	Positives
• May help with true obesity
	Negatives
• Must be medically supervised • Possible side effects both known and unknown • Not currently available in US at time of review • we would like to see more convincing customer testimonials or before & after pictures.
	Final Thoughts
Acomplia is clearly a pharmaceutical drug that is targeted toward those who are chronically and severely obese, and not for those who simply need to lose weight. As mentioned earlier it does have some known side effects such as depression, anxiety and nausea. It also affects the brain in a very new way which may eventually result in some other issues and side effects. It is for this reason we firmly believe that the use of this medication must be medically supervised. Nevertheless, this medication is not currently approved for use in the, US for a variety of reasons. As mentioned earlier, it is available from over seas distributors; however, we can not recommend nor support the acquisition of this medication through this method. For those who are not obese and who want to address issues around weight loss there are other holistically based and safe methods available to them. For instance, many consumers have achieved outstanding results with the use of Hoodia, an appetite suppressant, which has been proven to be able to convince the brain that the stomach is full – naturally and safely.

Information on Acomplia� (Rimonabant) (Possibly Zimulti�)

Sanofi-Synthelabo, a French Pharmaceutical Company created Rimonabant (Acomplia� and possibly Zimulti) which is a new drug treatment for obesity and possibly other ailments. This diet pill was officially approved in Britain on June 28th 2006. It has also be approved in several other European countries and other countries around the world. Which could someday lead the way to having the FDA approve it for the United States. But no guarantees, The FDA has strick policies regarding new medications on the market. And it recently did not approve it for the USA.

Acomplia (Rimonabant or Zimulti) diet pills offer hope for obese individuals. Especially where other treatments had little affect or whose side effects where too much to handle. This medication (as any) obviously does not come without some potential side effects for its user but could offer more that others. Rimonabant works differently than other weightloss pills, and has other potential benefits than any other diet drug. Studies also show that it increases levels of HDL (good cholesterol) while at the same time reducing the triglycerides (bad cholesterol). It could also possibly be used as a smoking cessation although not officially approved as one (yet).

Please Note the FDA has Not approved Rimonabant (Acomplia� Zimulti�) for use in the USA.
If you are from the USA proceed here. Be sure to read the disclaimer and follow all local laws regarding this medication. If you wish to inquire about this medication, see the following.

Buy Acomplia Rimonabant Zimulti in USA And Europe Online.

Acomplia Rimonabant (Zimulti), the new age diet pill is developed by world’s third largest French pharmaceutical Sanofi-Aventis, to help ever growing number of obese popula tion across the world.

This drug Rimonabant Acomplia works differently to most other weight loss drugs available in market.

Acomplia (Rimonabant) works in an entirely different way, by blocking CB1 a “pleasure center” in the brain, leading people to eat less and acting directly on fat cells to prevent weight gain. Sanofi Clinical research shows that Acomplia Rimonabant (Zimulti) also might help people quit smoking as well. Rimonabant clinical trial has proved its effectiveness in loosing weight as compared to other weight loss drugs. Rimonabant Acomplia treatment should be accompanied with a low calorie diet and an exercise plan to obtain considerable amount of weight loss. Buy Rimonabant Acomplia treatment online for a steady weight loss race.

What Is Rimonabant?

A single pill Rimonabant has been found to stop food craving enough to help people lose weight, and could also help curb other unhealthy urges. Named Rimonabant Acomplia the drug in one study helped people who were overweight drop an average of 20 pounds and very useful for the patients who suffer from obesity. Rimonabant Acomplia is made by French firm Sanofi-Synthelabo and the company says it is available now in Europe. Acomplia contains the active ingredient Rimonabant. It is a selective CB1 endocannabinoid receptor antagonist.

How does Rimonabant (Acomplia) work?

Rimonabant Acomplia works by blocking receptors of a substance called cannabinoid 1, which stimulates hunger and other cravings in the brain and is also present in fat tissue. This receptor is also present in the fat tissue and controls the hunger in the brain. So when you take this rimonabant drug, you will automatically eat less because you do not feel hunger. As a result you will take less food which helps you to reduce your cholesterol levels. When you start losing weight, the first place you will lose body fat is your mid-section. And your cholesterol will go down and your blood pressure will return to healthy levels.

Rimonabant Side Effects.

Rimonabant Acomplia was said to be well tolerated in early tests. The only relatively common side effects were mild GI side effects and dizziness, and these were said to be transient.

A Miracle? Rimonabant Acomplia - a real pharmaceutical help for weight loss, metabolic syndrome, and HDL levels may be on the horizon . It is thought that Rimonabant Acomplia is available from 28th june 2006.And you can buy Rimonabant Acomplia online through prescription given by our doctor.

Please note that Rimonabant Acomplia is available to purchase, you can buy it anywhere as it has been released!